Navigation Links
Health Enhancement Products Reacquires ProAlgaZyme(TM) Distribution and Marketing Rights
Date:10/2/2009

Company Better Positioned for Future Growth

SCOTTSDALE, AZ, Oct. 2 /PRNewswire-FirstCall/ - Health Enhancement Products, Inc. (OTC BB: HEPI.OB) and Changing Times Vitamins today announced, they have mutually agreed to terminate their current distribution agreement, in which Changing Times Vitamins had acquired the exclusive rights to distribute ProAlgaZyme (PAZ).

Under terms of the definitive agreement, HEPI retains all marketing and sales rights associated with the Company's proprietary ProAlgaZyme(TM) (PAZ) compound. HEPI will also retain control of all remaining inventory, labels, bottles, promotional materials, as well as customer contact information.

Peter Vitulli, Interim CEO of HEPI, commented, "Since joining the Company just a few short weeks ago, I have quickly recognized the immense potential that exists with our lead bioactive compound, PAZ. As such, I have initiated a series of steps to better position the Company for future growth. The first step is to control every aspect of PAZ's distribution, marketing and sales going forward. This decision is in the best interest of the Company as it allows us the freedom to evaluate multiple strategic options to maximize the true value of PAZ for our shareholders." Mr. Vitulli continued, "We continue to be greatly encouraged by the preliminary findings from Wayne State University and look forward to providing additional results in the coming weeks, along with more detailed information regarding the various opportunities available to the Company going forward."

About Health Enhancement Products, Inc.

Health Enhancement Products, Inc. (OTC BB: HEPI) is a health & wellness company engaged in the development of dietary supplements, food additives and ingredients using only pure, all-natural compounds. The Company's premier product is ProAlgaZyme (PAZ), a liquid product drawn from living algae grown in purified water. The water in which th
'/>"/>

SOURCE Health Enhancement Products, Inc.
Copyright©2009 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2

Related medicine news :

1. Penn study finds pro-death proteins required to regulate healthy immune function
2. UCLA researchers identify markers that may predict diabetes in still-healthy people
3. Air pollution linked to cardiovascular risk indices in healthy young adults
4. More proof needed of safety and quality of electronic personal health records
5. Health care incentive model offers collaborative approach
6. Loneliness is bad for your health
7. Mailman School of Public Health study examines link between racial discrimination and substance use
8. Green Tea May Brew Up Healthier Skin
9. For Health Info, Women Often Turn to the Web
10. Record Number of Americans Lack Health Insurance
11. U.S. Research Funding Continues to Flatten as U.S. Health Costs Climb - in August 31 Science

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... , NEW YORK, Nov. 20 /PRNewswire-FirstCall/...nced that it will broadcast Doctor Radio Report... , an in-depth special hosted by veteran journalis...om/cgi-bin/prnh/20080819/NYTU044LOGO ) ,, Doct... About Mammograms will air November 21 live at ...
(Date:11/20/2009)... durations of exposure to formaldehyde used for em...th an increased risk of death from myeloid leukemi...ber 20 in the Journal of the National Cancer Inst...tality from lymphohematopoietic malignancies and b...al industry workers, all of whom may have worked w...
(Date:11/20/2009)...ttle, Washington) November 20, 2009Emergency medic...sess an estimated 350,000 cardiac arrests each yea... cardiac arrest survive. Better quality cardiopul... EMS providers may be associated with better patie... (ROC) is the largest clinical research network to...
(Date:11/20/2009)... thinks it,s as short as 34 weeks, potentially add... , FRIDAY, Nov. 20 (HealthDay News) -- Recent r...ntinues to climb in the United States. Now, a new...fused about what constitutes a full-term birth in ...hers surveyed in the study considered a baby born ...
(Date:11/20/2009)...an study finds more severe cases than with seasona...ws) -- Canadian researchers are reporting that chi...e cases of H1N1 flu than seasonal flu. , "Asthm... for admission with pandemic H1N1 influenza, prese...es," wrote Dr. Upton Allen and fellow researchers ...
Breaking Medicine News(10 mins):Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 3Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 4Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 5Health News:Funeral industry workers exposed to formaldehyde face higher risk of leukemia 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 3Health News:Many Women Miscalculate Time to Full-Term Birth 2Health News:Many Women Miscalculate Time to Full-Term Birth 3Health News:Many Women Miscalculate Time to Full-Term Birth 4
...pril 23 I Lost It at the Club!, a,fitness industr...nated by,the International Health, Racquet & Sport... Foods, AllWhites(R), helped a total of 25,840,par...lub!, which ran for eight weeks from January 7 to ...
...h., April 23 Perrigo Company,(Nasdaq: PRGO ; TAS...results,for its third quarter fiscal 2008 on Tuesd...he Company will conduct a conference call at 10:00...ested,parties on the Perrigo website http://www.p...
...anted into mice, they improved heart function, res...ealthDay News) -- A multinational team of research...cells into three types of human heart muscle cells... be to use the cells to test drugs. , "We have now...
...nual Meeting, WASHINGTON, April 23 Medical devic...cials will gather for the 2008,Annual Meeting of t... on,June 12th and 13th at the Marriott at Metro Ce...l technology,companies. The Annual Meeting brings ...
... Property Expands to 41 Patents in more than 20 Co...Medical,Corporation, a medical products company de...performance through Aortic Flow Therapy, announced...,System and Method of Applying Same." The ,921 pat...
...if., April 23 Kaiser Permanente has,announced the...fornia,Member Service Call Centers. Ward previousl...ll Centers. She joined Kaiser Permanente in 1988.,...nclude more than 700 employees answering a wide va...
Other Medicine News:Health News:U.S. Health Club Members Proclaim - 'I Lost It at the Club!' and Lose 45 Tons of Excess Weight 2Health News:U.S. Health Club Members Proclaim - 'I Lost It at the Club!' and Lose 45 Tons of Excess Weight 3Health News:U.S. Health Club Members Proclaim - 'I Lost It at the Club!' and Lose 45 Tons of Excess Weight 4Health News:Embryonic Stem Cells Turned Into Three Types of Heart Cells 2Health News:Key Industry and Government Officials to Address Medical Technology Executives 2Health News:Orqis(R) Medical Awarded 15th U.S. Patent 2Health News:Trenita Ward Named Vice President, California Member Service Call Centers for Kaiser Permanente 2
(Date:11/20/2009)... NEW YORK, Nov. 20 Reportlinker.co...vailable in its catalogue. ,, Medical Adhesive...//www.reportlinker.com/p0164242/Medical-Adhesives-...prnewswire&utm_medium=pr&utm_campaign=prne...alants is gaining preeminence in medical devices a...
(Date:11/20/2009)...OUSTON, Nov. 20 Cyberoni... Moore, President and Chief Executive Officer, and...t at the 21st Annual Piper Jaffray Health Care Con... at 12:00 PM EST. The conference session and webc...e presented. Piper Jaffray will host a webcast of...
(Date:11/20/2009)...IS, Tenn., Nov. 20 Smi...ion is pleased to announce the signing of a techno...epartment of Defense that may lead to the creation...ionize the treatment of the limbs of soldiers who ... Defense Advanced Research Projects Agency (DARPA)...
Breaking Medicine Technology:Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 2Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 3Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 4Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 5Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 6Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference 2Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 2Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 3Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 4Conlon Wins Life Care 26apos 3Bs Heartland Division President 26apos 3Bs Award 57910 1Conlon Wins Life Care 26apos 3Bs Heartland Division President 26apos 3Bs Award 57910 2Cobb Pediatric Therapy Services Joins Forces with Travis Consulting LLC to Offer Expanded Services Across the U S 57905 1Cobb Pediatric Therapy Services Joins Forces with Travis Consulting LLC to Offer Expanded Services Across the U S 57905 2Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 1Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 2Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 3Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 4Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 5Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 6Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 7Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 8
...n To Affect 9-Fold More Longevity Genes Than Resve...t Alone - Independent Laboratory A...ers report that a,proprietary nutriceutical matrix...nes controlling energy metabolism, nine times broa...striction (mouse study --,Experimental Gerontology...
...se III Study Does Not Mean the End of Anti-Amyloid... studies,of potential new treatments for Alzheimer...l - increase the field,s knowledge and point scien..., according to research,reported today at the 2008...on Alzheimer,s Disease (ICAD 2008), in Chicago., ...
Other Medicine Technology:Video: Resveratrol-based Nutriceutical (Longevinex(R)) Induces Favorable Changes on Gene Expression in Mouse Heart At Doses 17-320 Times Lower Than Prior Studies 2Video: Resveratrol-based Nutriceutical (Longevinex(R)) Induces Favorable Changes on Gene Expression in Mouse Heart At Doses 17-320 Times Lower Than Prior Studies 3Four Alzheimer's Clinical Trials Address a Variety of Treatment Targets - Amyloid, Tau, Synapse Formation 2Four Alzheimer's Clinical Trials Address a Variety of Treatment Targets - Amyloid, Tau, Synapse Formation 3Four Alzheimer's Clinical Trials Address a Variety of Treatment Targets - Amyloid, Tau, Synapse Formation 4Four Alzheimer's Clinical Trials Address a Variety of Treatment Targets - Amyloid, Tau, Synapse Formation 5Four Alzheimer's Clinical Trials Address a Variety of Treatment Targets - Amyloid, Tau, Synapse Formation 6Four Alzheimer's Clinical Trials Address a Variety of Treatment Targets - Amyloid, Tau, Synapse Formation 7Four Alzheimer's Clinical Trials Address a Variety of Treatment Targets - Amyloid, Tau, Synapse Formation 8Four Alzheimer's Clinical Trials Address a Variety of Treatment Targets - Amyloid, Tau, Synapse Formation 9Four Alzheimer's Clinical Trials Address a Variety of Treatment Targets - Amyloid, Tau, Synapse Formation 10Four Alzheimer's Clinical Trials Address a Variety of Treatment Targets - Amyloid, Tau, Synapse Formation 11
Roche COMPACT 3 Blood Gas Analyzer
Roche OMNI S Blood Gas Analyzer
AGIT1006 Agitator
Horizon Series Platelet Agitator PF48h
Medicine Products: